Frataxin (Bioblast Pharma)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFrataxin (Bioblast Pharma)
Drug Alias NameFusion protein (Bioblast Pharma)BB-FA
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFrataxin, mitochondrial modulators
TargetsFrataxin, mitochondrial
Therapy Area/IndicationsFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnlivex Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnlivex Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsFriedreich Ataxia

Other Information

ATC CodeN/A
Related LinksN/A